Jeonjinbio Co., Ltd. (KOSDAQ:110020)
2,175.00
-25.00 (-1.14%)
At close: Feb 26, 2026
Jeonjinbio Revenue
Jeonjinbio had revenue of 4.45B KRW in the quarter ending September 30, 2025, a decrease of -15.19%. This brings the company's revenue in the last twelve months to 14.65B, down -26.58% year-over-year. In the year 2024, Jeonjinbio had annual revenue of 19.27B with 22.91% growth.
Revenue (ttm)
14.65B
Revenue Growth
-26.58%
P/S Ratio
1.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.27B | 3.59B | 22.91% |
| Dec 31, 2023 | 15.68B | 7.89B | 101.18% |
| Dec 31, 2022 | 7.79B | 4.58B | 142.48% |
| Dec 31, 2021 | 3.21B | -652.23M | -16.87% |
| Dec 31, 2020 | 3.87B | -82.35M | -2.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samjin LND | 145.41B |
| NC& Co.,Ltd | 99.35B |
| Spolytech | 73.97B |
| STO Co., Ltd. | 71.05B |
| PAKERS.Co.,Ltd. | 55.79B |
| Medience | 48.55B |
| Billions | 30.71B |
| Bellock | 25.24B |